Difference between revisions of "Inversion inv(11)(q21q23)"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
m (Snewman moved page Inv(11)(q21q23) to Inversion inv(11)(q21q23)) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| + | {{Under Construction}} | ||
| + | |||
[[File:inv(11)(q21q23).png|inv(11)(q21q23)]] | [[File:inv(11)(q21q23).png|inv(11)(q21q23)]] | ||
| + | |||
| + | [[Category:Inversion]] | ||
| + | [[Category:MDS]] | ||
| + | [[Category:AML M2]] | ||
| + | [[Category:T-ALL]] | ||
| + | [[Category:Inversions Chromosome 11]] | ||
| + | |||
| + | __TOC__ | ||
| + | |||
| + | == Contributors == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Description == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Tumor Types == | ||
| + | |||
| + | Write your comments here <ref>Test Reference: Nowell and Hungerford (1962). Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13939164] </ref> | ||
| + | |||
| + | == Prevalence == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Genes Involved == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Diagnostic Testing == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Clinical Significance == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Therapeutics == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Links == | ||
| + | |||
| + | ==References== | ||
Latest revision as of 11:03, 26 August 2016
 | This page is under construction |
(q21q23).png)
Contributors
Write your comments here
Description
Write your comments here
Tumor Types
Write your comments here [1]
Prevalence
Write your comments here
Genes Involved
Write your comments here
Diagnostic Testing
Write your comments here
Clinical Significance
Write your comments here
Therapeutics
Write your comments here